Literature DB >> 29874999

Inhibition of West Nile virus Replication by Bifunctional siRNA Targeting the NS2A and NS5 Conserved Region.

Divyanshi Karothia1, Paban Kumar Dash1, Manmohan Parida2, Sameer Bhagyawant3, Jyoti S Kumar1.   

Abstract

BACKGROUND: The West Nile Virus (WNV) has emerged as one of the most significant arboviral infection in many parts of the world and is associated with the encephalitis affecting mainly human and horses. In spite of the fact that the WNV is threat for the public health, there is no vaccine or therapeutic available for the treatment of WNV.
METHODS: In this study, we tested a novel RNA interference based technique to inhibit WNV replication in Vero cells. Two siRNAs were designed against the NS2A and NS5 regions of WNV which are highly conserved among Flaviviruses as it play important role in apoptosis and in viral replication respectively. In addition to this, dual functional siRNA is designed by joining an immunostimulatroy motif with the NS2A and NS5 specific siRNA. The antiviral activity was evaluated by detecting both the infectious virus and its genome.
RESULTS: The bifunctional siRNA resulted in significant reduction of virus titre in siRNA transfected cells as compared to controls. The antiviral efficacy was most effective at 48hr post infection. These results were in accordance with the quantitative RT-PCR assay revealing similar reduction in WNV genomic RNA. The expression of housekeeping gene was not affected by the siRNA indicating no off target effect and non-interference in cellular mechanism.
CONCLUSION: Thus, this bifunctional siRNA intervention paves the new way for therapeutic treatment of WNV disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Bifunctional siRNA; Flaviviruses; Immunostimulatory siRNA; RT-PCR; WNV; siRNA.

Mesh:

Substances:

Year:  2018        PMID: 29874999     DOI: 10.2174/1566523218666180607091311

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  3 in total

Review 1.  COVID-19 Vaccines: Current and Future Perspectives.

Authors:  Luca Soraci; Fabrizia Lattanzio; Giulia Soraci; Maria Elsa Gambuzza; Claudio Pulvirenti; Annalisa Cozza; Andrea Corsonello; Filippo Luciani; Giovanni Rezza
Journal:  Vaccines (Basel)       Date:  2022-04-13

2.  Small Interfering RNAs Are Highly Effective Inhibitors of Crimean-Congo Hemorrhagic Fever Virus Replication In Vitro.

Authors:  Fanni Földes; Mónika Madai; Henrietta Papp; Gábor Kemenesi; Brigitta Zana; Lili Geiger; Katalin Gombos; Balázs Somogyi; Ildikó Bock-Marquette; Ferenc Jakab
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

3.  siRNA Design to Silence the 3'UTR Region of Zika Virus.

Authors:  María Perez-Mendez; Paola Zárate-Segura; Juan Salas-Benito; Fernando Bastida-González
Journal:  Biomed Res Int       Date:  2020-08-02       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.